MB Bioplotas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 600 |
| - |
| 32 |
| 32 |
| - |
| 100.00 |
| 5.33 |
| 32 |
| 90,993 |
| 99,950 |
| 22,540 |
| -114.09 |
| 2,843.53 |
| - |
| - |
| 5.33 |
| 32 |
| 2025 |
|---|
| 9,819 |
| 9,819 |
| -36,442 |
| -36,442 |
| -36,442 |
| 100.00 |
| -371.14 |
| -36,409 |
| 77,738 |
| 81,748 |
| 8,090 |
| -7.09 |
| -2.14 |
| - |
| - |
| -371.13 |
| -36,441 |
| 2025 |
|---|
| 9,819 |
| 9,819 |
| -36,442 |
| -36,442 |
| -36,442 |
| 100.00 |
| -371.14 |
| -36,409 |
| 77,738 |
| 81,748 |
| 8,090 |
| -7.09 |
| -2.14 |
| - |
| - |
| -371.13 |
| -36,441 |
Turnover (€)
2025
Turnover (€)
9,819 €1,537 % *
Sales per employee (€)
9,819 €- *
Profit before tax (€)
-36,442 €-113,981 % *
Net Profit (€)
-36,442 €-113,981 % *
Profit per employee (€)
-36,442 €- *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-371.14 %-7,063.23 % *
Equity (€)
-36,409 €-113,878 % *
Amounts Payable And Liabilities (€)
77,738 €-15 % *
Non-current Assets (€)
81,748 €-18 % *
CurrentAssets (€)
8,090 €-64 % *
Working capital requirement
-7.09 93.79 % *
Debt-to-equity ratio
-2.14 -100.08 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-371.13 %-7,063.04 % *
EBIT (€)
-36,441 €-113,978 % *
